| (Values in U.S. Thousands) | Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 |
| Sales | 10 | 10 | 10 | 930 | 10 |
| Sales Growth | unch | unch | -98.92% | +9,200.01% | unch |
| Net Income | -6,450 | -6,530 | -7,480 | -6,950 | -7,630 |
| Net Income Growth | +1.23% | +12.70% | -7.63% | +8.91% | +6.72% |
Miromatrix Medical Inc (MIRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs. The Company's initial development focus is on human livers and kidneys. Miromatrix Medical Inc. is based in EDEN PRAIRIE, Minn.
Fiscal Year End Date: 12/31